TY - JOUR
T1 - Effects of tachykinins on phosphoinositide metaboism in the hypothalamus
T2 - is the NK1 receptor involved?
AU - Lebrun, C. J.
AU - Wende, P.
AU - Steckelings, U.
AU - Itoi, K.
AU - Unger, Th
N1 - Copyright:
Copyright 2014 Elsevier B.V., All rights reserved.
PY - 1993/12/31
Y1 - 1993/12/31
N2 - Substance P (SP) has been shown to stimulate the hydrolysis of inositol phospholipids in peripheral tissues and in the brain. In mammalian peripheral tissues, three tachykinin receptor subclasses, neurokinin 1 (NK1), neurokinin 2 (NK2) and neurokinin 3 (NK3), have been identified. The purpose of our study was to pharmacologically characterize the SP receptors in the hypothalamus using phosphoinositide breakdown as a functional response. SP, previously described as a NK1 agonist, and Neurokinin A (NKA), previously described as a NK2 agonist, stimulated phosphoinositide breakdown in the hypothalamus in a dose-dependent fashion, with SP being more potent than NKA. The NK2-selective antagonist L-659,877, at a dose of 10-6 M, abolished the effect of SP (10-8 M) without affecting basal phosphoinositide breakdown. However, this NK2-selective antagonist did not inhibit the NKA-induced stimulation on phosphoinositide metabolism. The NK-1-selective antagonist L-668,169 stimulated phosphoinositide metabolism at a concentration of 10-6 M, but not at 10-8 M. This NK1-receptor antagonist did not significantly inhibit the effect of SP on phosphoinositide metabolism. Spantide II, another NK1-selective antagonist, also stimulated phosphoinositide metabolism at a dose of 10-6 M. Like L-668,169, spantide II failed to inhibit the SP-induced stimulation of phosphoinositide metabolism, and even potentiated the response to SP. The blockade of the SP-induced phosphoinositide breakdown by the NK2-receptor antagonist (L-659,877), the absence of blockade of the NKA-induced phosphoinositide metabolism by the NK2 receptor antagonist and the absence of inhibition by the NK1 receptor antagonists (L-688,169 and spantide II) suggest that the SP-induced phosphoinositide metabolism in the hypothalamus is mediated by a receptor subclass different from those mediating the peripheral actions of SP.
AB - Substance P (SP) has been shown to stimulate the hydrolysis of inositol phospholipids in peripheral tissues and in the brain. In mammalian peripheral tissues, three tachykinin receptor subclasses, neurokinin 1 (NK1), neurokinin 2 (NK2) and neurokinin 3 (NK3), have been identified. The purpose of our study was to pharmacologically characterize the SP receptors in the hypothalamus using phosphoinositide breakdown as a functional response. SP, previously described as a NK1 agonist, and Neurokinin A (NKA), previously described as a NK2 agonist, stimulated phosphoinositide breakdown in the hypothalamus in a dose-dependent fashion, with SP being more potent than NKA. The NK2-selective antagonist L-659,877, at a dose of 10-6 M, abolished the effect of SP (10-8 M) without affecting basal phosphoinositide breakdown. However, this NK2-selective antagonist did not inhibit the NKA-induced stimulation on phosphoinositide metabolism. The NK-1-selective antagonist L-668,169 stimulated phosphoinositide metabolism at a concentration of 10-6 M, but not at 10-8 M. This NK1-receptor antagonist did not significantly inhibit the effect of SP on phosphoinositide metabolism. Spantide II, another NK1-selective antagonist, also stimulated phosphoinositide metabolism at a dose of 10-6 M. Like L-668,169, spantide II failed to inhibit the SP-induced stimulation of phosphoinositide metabolism, and even potentiated the response to SP. The blockade of the SP-induced phosphoinositide breakdown by the NK2-receptor antagonist (L-659,877), the absence of blockade of the NKA-induced phosphoinositide metabolism by the NK2 receptor antagonist and the absence of inhibition by the NK1 receptor antagonists (L-688,169 and spantide II) suggest that the SP-induced phosphoinositide metabolism in the hypothalamus is mediated by a receptor subclass different from those mediating the peripheral actions of SP.
KW - Hypothalamus
KW - Neurokinin A
KW - Phosphoinositol hydrolysis
KW - Senktide
KW - Substance P
KW - Tachykinin receptor antagonist
UR - http://www.scopus.com/inward/record.url?scp=0027723334&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0027723334&partnerID=8YFLogxK
U2 - 10.1016/0006-8993(93)91140-N
DO - 10.1016/0006-8993(93)91140-N
M3 - Article
C2 - 7511982
AN - SCOPUS:0027723334
VL - 632
SP - 74
EP - 79
JO - Molecular Brain Research
JF - Molecular Brain Research
SN - 0006-8993
IS - 1-2
ER -